Follow
Bisaglia Marco
Title
Cited by
Cited by
Year
Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with α-synuclein
M Bisaglia, S Mammi, L Bubacco
Journal of Biological Chemistry 282 (21), 15597-15605, 2007
3292007
Structural insights on physiological functions and pathological effects of▒‐synuclein
M Bisaglia, S Mammi, L Bubacco
The FASEB Journal 23 (2), 329-340, 2009
1922009
A topological model of the interaction between α-synuclein and sodium dodecyl sulfate micelles
M Bisaglia, I Tessari, L Pinato, M Bellanda, S Giraudo, M Fasano, ...
Biochemistry 44 (1), 329-339, 2005
1452005
Copper ions and Parkinson’s disease: why is homeostasis so relevant?
M Bisaglia, L Bubacco
Biomolecules 10 (2), 195, 2020
1372020
The reaction of α-synuclein with tyrosinase: Possible implications for Parkinson disease
I Tessari, M Bisaglia, F Valle, B Samorý, E Bergantino, S Mammi, ...
Journal of biological chemistry 283 (24), 16808-16817, 2008
1362008
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N Plotegher, G Berti, E Ferrari, I Tessari, M Zanetti, L Lunelli, E Greggio, ...
Scientific reports 7 (1), 40699, 2017
1312017
Probing the relationship between Gram-negative and Gram-positive S1 proteins by sequence analysis
P Salah, M Bisaglia, P Aliprandi, M Uzan, C Sizun, F Bontems
Nucleic acids research 37 (16), 5578-5588, 2009
1122009
Dopamine quinones interact with α-synuclein to form unstructured adducts
M Bisaglia, L Tosatto, F Munari, I Tessari, PP de Laureto, S Mammi, ...
Biochemical and Biophysical Research Communications 394 (2), 424-428, 2010
1102010
DJ-1 is a copper chaperone acting on SOD1 activation
S Girotto, L Cendron, M Bisaglia, I Tessari, S Mammi, G Zanotti, ...
Journal of Biological Chemistry 289 (15), 10887-10899, 2014
1052014
Anti-oxidants in Parkinson’s disease therapy: a critical point of view
R Filograna, M Beltramini, L Bubacco, M Bisaglia
Current Neuropharmacology 14 (3), 260-271, 2016
1012016
Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease
M Bisaglia, ME Soriano, I Arduini, S Mammi, L Bubacco
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 (9), 699-706, 2010
992010
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
M Bisaglia, R Filograna, M Beltramini, L Bubacco
Ageing research reviews 13, 107-114, 2014
932014
Broken helix in vesicle and micelle-bound α-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations
M Bortolus, F Tombolato, I Tessari, M Bisaglia, S Mammi, L Bubacco, ...
Journal of the American Chemical Society 130 (21), 6690-6691, 2008
922008
Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease
A Biosa, F Sandrelli, M Beltramini, E Greggio, L Bubacco, M Bisaglia
Neurobiology of disease 108, 65-72, 2017
912017
Pathogenic Mutations Shift the Equilibria of α‐Synuclein Single Molecules towards Structured Conformers
M Brucale, M Sandal, S Di Maio, A Rampioni, I Tessari, L Tosatto, ...
ChemBioChem 10 (1), 176-183, 2009
912009
Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE (2)-M17 neuroblastoma cell lines upon differentiation
R Filograna, L Civiero, V Ferrari, G Codolo, E Greggio, L Bubacco, ...
PLoS one 10 (8), e0136769, 2015
872015
Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53
S Girotto, M Sturlese, M Bellanda, I Tessari, R Cappellini, M Bisaglia, ...
Journal of Biological Chemistry 287 (22), 18738-18749, 2012
872012
Interaction between α-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson’s disease
M Bisaglia, I Tessari, S Mammi, L Bubacco
Neuromolecular medicine 11, 239-251, 2009
872009
Structure and topology of the non‐amyloid‐β component fragment of human α‐synuclein bound to micelles: Implications for the aggregation process
M Bisaglia, A Trolio, M Bellanda, E Bergantino, L Bubacco, S Mammi
Protein science 15 (6), 1408-1416, 2006
852006
Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson’s disease
E Belluzzi, M Bisaglia, E Lazzarini, LC Tabares, M Beltramini, L Bubacco
PloS one 7 (6), e38026, 2012
822012
The system can't perform the operation now. Try again later.
Articles 1–20